BioMarin Pharmaceutical, Inc. (BMRN)
57.52
+1.30
(+2.31%)
USD |
NASDAQ |
Apr 08, 13:13
BioMarin Pharmaceutical Cash from Investing (TTM) : -414.24M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amicus Therapeutics, Inc. | -46.43M |
| Ionis Pharmaceuticals, Inc. | -277.78M |
| Mirum Pharmaceuticals, Inc. | -23.95M |
| Hims & Hers Health, Inc. | -1.025B |
| ACADIA Pharmaceuticals, Inc. | -302.56M |